Market Place
Sourcing Support
All News #Library
Biotech
Takeda Inks $1.7B AI Discovery Deal With Iambic Therapeutics
09 Feb 2026 //
FIERCE BIOTECH
Iambic Therapeutics Lines Up Over $100M In New Funding
10 Nov 2025 //
FIERCE BIOTECH
Iambic Shares Clinical Data from Ph1/1B Study of IAM1363
20 Oct 2025 //
BUSINESSWIRE
Revolution taps Iambic`s AI models in $25M Discovery Deal
10 Jul 2025 //
FIERCE BIOTECH
Revolution Med, Iambic Collaborate on AI-Driven Drug Discovery
09 Jul 2025 //
GLOBENEWSWIRE
Iambic Announces Enchant v2, Next Gen AI for Drug Viability
05 May 2025 //
BUSINESSWIRE
Iambic debuts next version of AI model Enchant, new way for R&D
05 May 2025 //
ENDPTS
Iambic to Participate in Upcoming Investor Conferences
25 Mar 2025 //
BUSINESSWIRE
Iambic to Participate in Upcoming Investor Conferences
03 Mar 2025 //
BUSINESSWIRE
Iambic Therapeutics Appoints Michael Secora As CFO And CDO
06 Jan 2025 //
BUSINESSWIRE
Iambic Therapeutics to Present at J.P. Morgan Health Conference
18 Dec 2024 //
BUSINESSWIRE
Iambic Names Peter Olson, Ph.D., As Chief Scientific Officer
11 Dec 2024 //
BUSINESSWIRE
Iambic Therapeutics Launches “Enchant,” an AI Platform
29 Oct 2024 //
BUSINESSWIRE
Iambic Therapeutics Named To Endpoints 11 List Of Startups
27 Sep 2024 //
BUSINESSWIRE
AI-driven biotech Iambic snags $100M to enter the clinic next year in HER2 field
03 Oct 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.